Page URL:

Deaf mice able to hear 'whispers' after gene therapy

13 February 2017
Appeared in BioNews 888

An improved gene-therapy technique using a synthetic virus has restored the hearing of deaf mice up to the level of a whisper.

This technique might eventually be used to treat fetuses affected by Usher syndrome, a genetic condition responsible for three to six percent of childhood deafness, preventing them from being born deaf.

Last week, researchers at Harvard Medical School partially restored the hearing of genetically deaf mice using a separate gene therapy technique (see BioNews 887). Those mice were able to hear sounds at around 70–80 decibels – some mice in the present study could hear sounds as quiet as 25–30 decibels. The treatment also restored the mice's balance, which is affected by the condition.

'Now, you can whisper, and they can hear you,' said Dr Gwenaëlle Géléoc at Boston Children's Hospital, who led the study, which was published in Nature Biotechnology.

The mice were genetically engineered to have a mutation in the Ush1c gene, the same gene that causes Usher syndrome. The gene normally produces a protein called harmonin, without which the hair cells in the ear deteriorate.

Previous gene therapy techniques had only been able to penetrate the inner hair cells, but in a separate study in the same issue of Nature Biotechnology, scientists at Harvard demonstrated that they could penetrate 80–90 percent of both inner and outer hair cells, using a synthetic virus to deliver a functional Ush1c gene into the cells.

Using this improved technique, Dr Géléoc was able to treat the deaf mice. 'This strategy is the most effective one we've tested,' she said. 'Outer hair cells amplify sound, allowing inner hair cells to send a stronger signal to the brain. We now have a system that works well and rescues auditory and vestibular function to a level that's never been achieved before.'

After treatment the hair cells grew normally, and the effects persisted for at least six months. The mice had to be treated straight after birth or the therapy was not effective. The therapeutic window in humans would likely be in the uterus while the cochlea is still developing.

'This is a very encouraging result … but it is only in a mouse model. One of the biggest risks is that the new synthetic viral vector has not been given to humans yet,' said Professor Alan Boyd, president of the Faculty of Pharmaceutical Medicine, who was not involved in the study. He estimates that human trials are at least three years away.

The researchers say that this approach could be effective for more than 100 genetic disorders that affect hearing in people.

19 October 2020 - by Eleanor Mackle 
After a mere 22 years of study, researchers in the Netherlands have finally pinpointed the genetic cause behind one type of hearing loss. This sounds potentially ground-breaking, so I was excited to learn more about the story in the 'Deafness Gene Identified' podcast, by The Naked Scientists...
16 October 2017 - by Dr Greg Ball 
Researchers have discovered 52 new genes essential for hearing in mice...
27 February 2017 - by Caroline Casey 
Scientists have developed a way of growing thousands of human hair cells – sensors in the inner ear that detect sound – from stem cells...
17 February 2017 - by Dr Molly Godfrey 
A Canadian man with Fabry disease – a rare, inherited enzyme deficiency – is the first person to be given gene therapy for the condition...
6 February 2017 - by Caroline Casey 
A novel gene therapy technique has partially restored hearing and balance in deaf mice...
13 July 2015 - by Dr Greg Ball 
A technique that delivers genes into the inner ears of mice has been used to restore hearing, marking the first time that gene therapy has been successfully used to treat deafness...
11 February 2013 - by Reuben Harwood 
A short strip of genetic material has been used to prevent hereditary deafness in mice...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.